Women all around the country are continuing to file transvaginal mesh (TVM) lawsuits against manufacturers of this product that has caused serious complications that often lead to the need for surgical removal of the device. Erosion is a common issue that can lead to severe pelvic injuries.
Women all over the world have been treated for stress urinary incontinence and pelvic organ prolapse (POP) with transvaginal mesh (TVM).
A judge in New Jersey has ruled that a South Dakota woman’s trial against transvaginal mesh manufacturer Johnson & Johnson had overwhelming evidence and an appropriate jury, so the company’s plea to overturn the $11 million award was denied.
Pelvic organ prolapse (POP) and stress urinary incontinence are not uncommon for women to experience, and these conditions are often treated with transvaginal mesh.
Women all around the country are continuing to file transvaginal mesh (TVM) lawsuits against manufacturers of the devices. In July 2014, a joint TVM status conference will take place in the U.S. District Court, Southern District of West Virginia where there are currently several federal litigations taking place.
Earlier in 2014, the U.S. Food and Drug Administration sent a warning letter to American Medical Systems (AMS) following a growing number of lawsuits against the company due to faulty transvaginal mesh devices (TVM), and a statement from parent company Endo International PLC announced that AMS will move forward with the 522 postmarket surveillance study for the Elevate product.
Transvaginal mesh lawsuits continue to be filed in courts around the U.S. as women who were treated with the device after suffering pelvic organ prolapse (POP) or stress urinary incontinence, but they suffered serious complications that lead to the need to surgical removal of the mesh.
Women around the country are continuing to file transvaginal mesh (TVM) lawsuits against manufacturers of the devices that are used to treat pelvic organ prolapse (POP) and stress urinary incontinence because the mesh can lead to serious complications and require surgical removal.
American Medical Systems, which manufactures transvaginal mesh devices, received a warning letter from the U.S. Food and Drug Administration (FDA) regarding issues the organization found at a facility run by the company. These included risk analysis and process validation procedures.
Women all around the country are filing transvaginal mesh (TVM) lawsuits against manufacturers of these devices after needing removal surgery because of complications with the mesh.